Chris Kemmerer
Plus aucun poste en cours
Profil
Chris Kemmerer worked as a Director of Pharmaceutical Development at Avera Pharmaceuticals, Inc. and as a Principal at Merck & Co., Inc. and Pfizer Inc. He also served as the VP of Pharmaceutical Development & Manufacturing at Neothetics, Inc. from 2009 to 2016.
Dr. Kemmerer holds a doctorate degree from Temple University and an undergraduate degree from The Pennsylvania State University.
Anciens postes connus de Chris Kemmerer
| Sociétés | Poste | Fin |
|---|---|---|
Neothetics, Inc.
 Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2016 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Avera Pharmaceuticals, Inc.
 Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avera Pharmaceuticals, Inc. develops drugs and therapies. The company's pharmaceutical compounds are used to identify opportunities for therapeutic advances in the treatment of neurological and psychiatric disorders. Avera Pharmaceuticals was founded in 2002 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formation de Chris Kemmerer
| The Pennsylvania State University | Undergraduate Degree |
| Temple University (Pennsylvania) | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Neothetics, Inc.
Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Health Technology |
Avera Pharmaceuticals, Inc.
Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avera Pharmaceuticals, Inc. develops drugs and therapies. The company's pharmaceutical compounds are used to identify opportunities for therapeutic advances in the treatment of neurological and psychiatric disorders. Avera Pharmaceuticals was founded in 2002 and is headquartered in San Diego, CA. | Health Services |